Alteration in p53 modulates glial proteins in human glial tumour cells

Journal of Neuro-Oncology

Volumn 48, Issue 3, 2000, Pages 191-206

  Sang, U H ^a,b   Banaie, A ^a,b   Rigby, L ^a,b   Chen, J ^a,b   Meltzer, H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Glial proteins; Human gliomas; p53

Indexed keywords

BUCLADESINE; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE SYNTHASE; MESSENGER RNA; PROTEIN P53; RETINOIC ACID; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BRAIN NEOPLASMS; BUCLADESINE; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; GLUTAMATE-AMMONIA LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPYRUVATE HYDRATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033768998     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006453316656     Document Type: Article

References (59)

1. Differentiation of astrocytes in the cerebellar cortex and the pyramidal tracts of the newborn rat. An immunofluorescence study with antibodies to a protein specific to astrocytes
2. Induction of some features of glial differentiation in primary culture of human gliomas by treatment with dibutyryl cyclic AMP
3. Continuous human glioma-derived cell lines UC-11MG and UC-302MG
4. Properties of human malignant glioma cells in vitro
5. Cyclic AMP regulates the rate of differentiation of oligodendrocytes without changing the lineage commitment of their progenitors
6. Induction of oligodendrocyte differentiation by activators of adenylate cyclase
7. PKA and PKC activation induces opposite glial fibrillary acidic protein (GFAP) expression and morphology changes in a glioblastoma multiform cell line of clonal origin
8. Glial fibrillary acidic protein (GFAP) expression and nucleolar organizer regions (NORs) in human gliomas
9. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2
10. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
11. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent phosphorylation and release from SV40 large T
12. Oncogenes and growth control
13. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
14. Transcriptional activation by wild-type but not transforming mutants of the p53 antioncogene
15. Proto-oncogene abnormalities and their relationship to tumorigenicity in some human glioblastomas
16. Astrocytes derived from p53-deficient mice provide a multi-step in vitro model for development of malignant gliomas
17. Chromosome 17 deletions and p53 gene mutations on colorectal carcinomas
18. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
19. Mutations in the p53 gene occur in diverse human tumour types
20. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
21. Different tumor-derived p53 mutants exhibit distinct biological activities
22. Regulation of the specific DNA binding function of p53
23. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
24. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
25. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells
26. p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors
27. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis
28. Genetic mechanisms of tumor suppression by the human p53 gene
29. Modulation of Mr 53,000 protein with induction of differentiation of human neuroblastoma cells
30. Induction of p21 (WAR-1/CIP1) during differentiation
31. p21WAP1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx
32. Overexpression of p21WAP1/Cip1 induces cell differentiation and growth inhibition in a human glioma cell line
33. Early events in murine erythroleukemia cells induced to differentiate
34. An antisense RNA involved in p53 mRNA maturation in murine erythroleukemia cells induced to differentiate
35. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO
36. Modulation of the c- myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation
37. Tumor suppressor p53: Analysis of wild- type and mutant p53 complexes
38. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
39. Cytogenetic diagnosis of brain tumors
40. p53 mutations in human cancers
41. Characterization of the human p53 gene
42. DNA sequencing with chain terminating inhibitors
43. The role of the epidermal growth factor receptor (EGF-R) in human gliomas: II. The control of cell growth
44. The role of the epidermal growth factor receptor (EGF-R) in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein (GFAP)
45. Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes
46. An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures
47. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells
48. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
49. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein
50. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport
51. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decrease stability of the protein
52. Involvement of wild-type p53 protein in the cell cycle requires nuclear localization
53. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins
54. Presence of a potent transcription activating sequence in the p53 protein
55. WAF1, a potential mediator of p53 tumor suppression
56. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
57. p21 is a universal inhibitor of cyclin kinases
58. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
59. The retinoblastoma protein and cell cycle control